In the eWAT, CBPs treatment markedly downregulated the mRNA expression of PPARα, PPARγ, acetyl-coenzyme A carboxylase 1 (ACC1), sterol regulatory element binding protein-1c (SREBP-1c), CCAAT enhancer binding protein α (C/EBPα), fatty acid synthetase (FAS) and enhanced the mRNA expression of hormone-sensitive lipase (HSL) in AM group rats compared with HF group rats (Fig. 3d). This evidence concerns the gene PPARG and hydrops fetalis.